PR Contact » DatelineMedia

Sydney, Australia +61 2 9006 1614
Palo Alto, USA +1 650 798 5238
New York, USA +1 212 351 5054
contact@datelinemedia.com
www.datelinemedia.com

Sydney » New York » San Francisco

Latest News

BRW

Resistance to tuberculosis alarming.

Click here for further information [PDF 180KB]

Bio NJ

The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.

Click here for further information [PDF 60KB]

BioTechnologyNews.net

Proteome ticks off new BD milestone.

Click here for further information [PDF 168KB]

IT Conversations

Dr. Jenny Harry CEO, Proteome Systems. On Biotech Nation, Dr. Moira Gunn speaks with Dr. Jenny Harry, who talks about the latest developments in a semen-based prostate cancer test, while David Ewing Duncan talks about a longevity pill.

Click here to listen to audio

Life Scientist

TB diagnostic agreement for Proteome Systems, Sputum-based test to be developed by Proteome Systems and BD.

Click here for further information [PDF 56KB]

MBC (Massachusetts Biotech Council)

Proteome Systems. US and Australian Biotechs Collaborate to Develop New Semen-Based Non-Invasive Prostate Cancer Test; Prostate Cancer Associated Biomarker Identified by Proteome Systems Just Days Prior to Prostate Cancer Awareness Month.

Click here for further information [PDF 72KB]

Click News above for more news

you need flash player to use the video

Press Releases

11 March 2008
The Bill & Melinda Gates Foundation, BIO, and BIO Ventures For Global Health invite Proteome Systems' CEO to speak on TB Diagnostics Solutions at Partnering For Global Health Forum, Washington D.C

29 February 2008
Proteome Systems Secures Cornerstone Investor

11 February 2008
Proteome Systems reaches latest milestone in agreement with BD to develop Tuberculosis diagnostics

02 July 2007
Proteome Systems Announces Agreement With BD for Development of Tuberculosis Diagnostics

25 May 2007
Proteome Systems announces new CEO succession

01 May 2007
Proteome Systems announces international licensing & commercialisation opportunity for its Eukarion compounds

27 April 2007
Proteome Systems sells rights to technology products and focuses on core discovery and diagnostics business

Click Press Releases above for more press releases